July Social Media Round-Up—Fireside Chat, Newsweek AI Impact Awards, and More
While you’re relaxing on your summer vacation, catch up on Pfizer's social media to see everything we've been up to this July.
Expanding Global Impact with Dr. Sue Desmond-Hellman: The Power of Knowing, Episode Two
To explore how AI is transforming the way we work, lead, and shape the future, earlier this year, Pfizer launched “The Power of Knowing,” a new video series that explores the burgeoning technology’s evolving role in all our lives.
June Social Media Round-Up—Father’s Day, 2024 Impact Report, and More
On our corporate channels, we shared empowering patient stories, presented positive data at major conferences, and highlighted the latest episodes of “Dear Scientist,” “Front Porch Conversations,” and “Specialty Voices of Innovation.”
Pfizer Launches “Power of Knowing” Video Series with Chief Digital and Technology Officer
Once confined to the realms of science and research, artificial intelligence (AI) has quickly become a part of our day-to-day lives. As the technology continues to grow, integrating itself into all corners of modern life, one thing is for certain: there’s no avoiding it.
Five Steps to Good Health: Essential Advice for Men
It’s become a cliché that many men don’t take care of their health as well as women do and that they’re less likely to see a doctor. But is the cliché true? Unfortunately, data offer some support. Men are less likely to keep up with regular check-ups and get medical care than women are. At Pfizer, we want to change these trends and empower men with the information they need to take control of their health. June is Men’s Health Month making it a great time to remind the dads in our lives about the importance of a healthy lifestyle.
Pfizer Provides Update on U.S. Regulatory Review of TALZENNA in Combination with XTANDI for Broader Use in Metastatic Castration-Resistant Prostate Cancer
New York, June 13, 2025 – Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration’s (FDA) decision on the supplemental New Drug Application (sNDA) for TALZENNA® (talazoparib) in combination with XTANDI® (enzalutamide) for men with metastatic castration-resistant prostate cancer (mCRPC).
Pfizer’s 2024 Impact Report Highlights Accomplishments in Sustainability, Responsibility
When Pfizer talks about making breakthroughs that change patients’ – and people’s – lives, we aren’t simply referring to scientific discovery and game-changing medicines. We’re talking about the impact we have on those patients and peoples’ lives, the impact our work has on the world and the environment, and our efforts towards making our medicines available and accessible to as many people as possible.
May Social Media Round-Up—Q1 Earning Results, Bladder Cancer Awareness Month, and More
The month of May flew by with more exciting updates and announcements from Pfizer across social media. Time flies when you’re making breakthroughs. See what else we got up to this month and follow our channels for more.
The Mindfulness of Medicine Development: A Scientist’s Work Is Never Done
Pfizer has a long history in vaccine research and development, and through the development of innovative delivery systems and technologies, we’ve created solutions to help prevent infection with and the severity of many infectious diseases. In the final installment of “The Mindfulness of Medicine Development,” we hear from Isis, Senior Director and bacterial vaccines expert at Pfizer, who works directly on these advancements and continues to apply her expertise to next-generation vaccines research.
Pfizer and BioNTech Submit EMA Application for COVID-19 Vaccine Targeting LP.8.1 for 2025-2026 Season
NEW YORK and MAINZ, GERMANY, MAY 28, 2025 -- Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced that they have submitted a regulatory application to the European Medicines Agency (EMA) for approval of COMIRNATY® for the 2025-2026 season, targeting the LP.8.1 strain.